What Happened?
Morrisville, NC-based Arrivo BioVentures Appointed Michael Ackermann as Co-Founder and Chief Business Officer
About the Company
We are a biopharmaceutical company focused on accelerating biologics and small molecules through clinical development that have the potential to improve patient lives. We are a team of seasoned pharmaceutical and start-up professionals with an extensive track record of success. Our expertise is in fast, efficient and high quality drug development. Whether developing a reformulated product or a new chemical entity, our management team has expertise to identify regulatory strategies to expedite the path to approval through efficient clinical programs.
About the Person
Michael Ackermann is Co-Founder and Chief Business Officer at Arrivo BioVentures . Previously, Michael held various senior HR leadership roles in the industry.
Info Source
News
Short Profile